Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.
Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.
复制标题
DOI:
10.1182/bloodadvances.2022008996
复制
发表时间:
2023-05-09
期刊:
影响因子:
7.5
通讯作者:
Loh, Kah Poh
中科院分区:
文献类型:
--
作者:
LoCastro, Marissa;Sanapala, Chandrika;Mendler, Jason H.;Norton, Sally;Bernacki, Rachelle;Carroll, Thomas;Klepin, Heidi D.;Watson, Erin;Liesveld, Jane;Huselton, Eric;O'Dwyer, Kristen;Baran, Andrea;Flannery, Marie;Kluger, Benzi;Loh, Kah Poh
We adapted an SICP to be delivered via telehealth for older adults with hematologic malignancies. The adapted SICP may facilitate earlier advance care planning discussions. Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) experience intense inpatient health care at the end-of-life stage. Early advance care planning may improve care at the end of life for patients with AML or MDS. The Serious Illness Care Program (SICP) is a multicomponent, communication intervention developed to improve conversations about values for patients with serious illnesses. The SICP has been shown to improve the quality and frequency of advance care planning discussions. We adapted the SICP for delivery via telehealth to older patients with AML or MDS. We conducted a single-center qualitative study of 45 participants (25 clinicians, 15 older patients with AML or MDS, and 5 caregivers). Participants, whether clinicians, patients, or caregivers, agreed that the SICP would help older patients with AML or MDS to share their personal values with their care team. Four qualitative themes emerged from our data: (1) serious illness conversations can be conducted via telehealth, (2) older patients have limited experience using technology but are willing and able to learn, (3) patients feel that serious illness conversations will help them understand their AML or MDS diagnosis and prognosis better, and (4) serious illness conversations should be common and routine, not extraordinary. The adapted SICP may provide older patients with AML or MDS an opportunity to share what matters most to them with their care team and may assist oncologists in aligning patient care with patient values. The adapted SICP is the subject of an ongoing single-arm pilot study at the Wilmot Cancer Institute (clinicaltrials.gov identifier: NCT04745676).
登录
查看更多内容
影响因子:
4.7
作者:
Abdallah M;Xie Z;Ready A;Manogna D;Mendler JH;Loh KP
通讯作者:
Loh KP
影响因子:
2.9
作者:
Bernacki R;Hutchings M;Vick J;Smith G;Paladino J;Lipsitz S;Gawande AA;Block SD
通讯作者:
Block SD
影响因子:
3.5
作者:
Ftouni, Racha;AlJardali, Baraa;Hamdanieh, Maya;Ftouni, Louna;Salem, Nariman
通讯作者:
Salem, Nariman
影响因子:
6.2
作者:
Alibhai, Shabbir M. H.;Leach, Marc;Brandwein, Joseph
通讯作者:
Brandwein, Joseph
影响因子:
2.2
作者:
Agarwal R;Epstein AS
通讯作者:
Epstein AS